Dermatology Days of Paris

/in , , , , /by

2nd December

The 7th Conference of the French Federation for Skin (FFP) was held, as usual, in Paris Convention Center, as a preamble of the Dermatology Days of Paris (JDP). Therapeutic revolutions, Clinical Trials, Alternatives to Desertification and Integrative Health: 4 themes developed in the round table discussions. They captivated the audience and highlighted the work carried out by the FFP to improve patients’ quality of life.

3rd-6th December

Having a stand in the village of associations during the Dermatological Days of Paris (JDP) is an opportunity, every year, to increase Cutis Laxa’s visibility. It is also an opportunity to meet doctors, researchers and laboratories interested in our pathology and the projects we are carrying out. AND it’s always nice to meet up with our colleagues and friends from the associative world. This year, our visibility increased even more with our poster alongside those of doctors and researchers.

Have a look at the JDP2025 retrospective were Marie-Claude Boiteux talks about the Associations’ village (at 1:04)

The role of ERNs in boosting EU competitiveness through public-private partnerships

/in , , /by

Together for Rare Diseases (Together4RD) has published a report on the use of public-private partnerships (PPPs) in rare disease research, and the role ERNs have to play in this context in order to boost European competitiveness and drive change for the rare disease community. The report was developed following a high-level conference hosted by MEPs Stine Bosse (Renew Europe, Denmark) and András Kulja (EPP, Hungary), in collaboration with Together4RD, at the European Parliament on 24 September.

Drawing on the discussions held during the conference, the report puts forward a number of action items to facilitate ERN-industry collaboration, thereby accelerating innovation and improving the availability of treatments and care for patients. Some of the actions outlined in the report are:

  • Ensure the Biotech Act, Life Sciences Strategy and Multiannual Financial Framework promote collaborative research and provide resources for ERNs and industry to enter research partnerships.
  • Revise the 2019 ERN Board of Member States (BoMS) statement to explicitly allow and encourage ERN-industry research and data collaboration.
  • Develop and deploy a standardised EU-wide contracting and data-sharing framework for ERN-industry partnerships.
  • Support ERNs in becoming legal entities or forming shared-governance structures to streamline partnerships.
  • Establish an EU Rare Disease Action Plan with measurable targets and stable funding.

By combining the expertise of ERNs, the capabilities and resources of industry, and the input of patient communities, this type of PPP has the potential to deliver concrete change and improved health outcomes for all Europeans living with a rare disease. (© Orphanews 2025.11.25)

Can cognitive behavioural group therapy help people living with a rare disease?

/in , /by

People living with a rare disease (PLWRD) often experience significant psychological burden, that results from a number of factors including physical pain, reduced income and increased medical expenses, and reduced social interactions. In addition, chronic physical conditions, as in most rare diseases, often occur alongside depression which can further exacerbate other mental health effects of the disease itself. In order to address this issue, a study was recently published in Intractable & Rare Diseases Research that investigates the effects of a mindfulness-based cognitive behavioural group therapy program for patients with a rare disease and deep depression.

The program described in the article consisted of three monthly sessions, each lasting 2 hours. Overseen by a clinical psychologist, it was designed to reduce psychological stress and improve quality of life in People Living With a Rare Disorder. (©Orphanews international 2025.10.06)

Globalskin Europe and EADV in Paris

/in , , , /by

16th September : GLOBALSKIN

Globalskin Europe members met in Paris about Advocacy Strategies, working on opportunities and challenges when interacting with national and/or European policy makers.

A great opportunity to meet with colleague Patient Organisation Leaders

17th-20th September : EADV

The European Academy of Dermatology-Venerology (EADV) held its annual conference in Paris.

Besides the possibility to have a booth increase the visibility of Cutis Laxa, Marie-Claude Boiteux spoke about the successes and projects led by the Patient Representatives (ePAGS) during the session dedicated to the work done in ERN-Skin.

Pregnancy and Family Planning in Rare Disorders

/in , , /by

Orphanet Journal of  Rare Diseases published the results of the survey for healthcare professionals « Pregnancy and Family Planning in Rare Diseases”

(read the publication)

 Written by the European Reference Networks (ERNs) transversal working group that brings together patient representatives (EPAGs) (of which Marie-Claude Boiteux) and healthcare professionals (HCP) from 20 ERNs . After identifying 7 transversal domains to be explored in the survey (Fertility preservation, Pre-conceptional counseling, Family Planning counseling, Pre-implantation diagnosis, Prenatal diagnosis, Pregnancy monitoring, Post pregnancy monitoring/ lactation monitoring/counseling/newborn management), the group established closed and open-ended questions for each domain. These questions explored the level of importance, the activities performed by the center, the clinical challenges, the good practice and the educational activities related to the selected topics.

HCP, from 24 different countries answered the survey.

“Pre-conceptional counselling” and “pregnancy monitoring” were mentioned as important/very important at 83.3% and 75.6%, respectively. And « Family Planning Counselling » was considered very important/important at 71,6%.

The conclusions of this survey are pointing unmet needs for HCPs, including the need to improve communication between different HCPs, the lack of predefined organizational pathways, the lack of availability of expert HCPs for some pregnancy-related issues and the need to streamline the care provided among different European countries.

In addition, the survey underlined the need to improve the educational activities provided to ra

re disease patients.

Overall, the results pointed out the need to educate both physicians and patients on the basis of the emerging unmet needs. Online resources can be an excellent educational tool, they may help in disseminating and standardizing educational activities in order to homogenize the information for HCPs and patients.

Therefore, initiatives in this direction by scientific societies, ERNs and patient associations should be promoted and encouraged

A second questionnaire had been sent to patients. The answers are being analysed and should be soon published. It will then be possible to compare HCPs’ and patients’ views.

ERN-Skin Activities

/in , , , /by

16th January 2025 : Executive Committee (on line)

This annual meeting highlights the main aims, and projects for the coming years

2nd-3rd July 2025 : Scientific Days

The latest research on each pathology, clinical cases and the work of young researchers were presented so we would be updated on the work and projects led in our European network.

The work done by patient representatives was also honored with Marie-Claude Boiteux’s presentation of the publication « Pregnancy and Family Planning in Rare Disorders – A Heathcare Professionals survey » (see the post on this survey)

cmgg-Pr Bert CALLEWAERT

Astrazeneca awarded its « Scientific Prize 2024 » to Pr Bert Callewaert .

/in , , , /by

On 12th December 2024, Astrazeneca awarded its « Scientific Prize 2024 » to Pr Bert Callewaert .

We are very happy and proud that Pr Callewaert is one of the rare worldwide experts on Cutis Laxa. He is awarded the prize for his research on congenital rare diseases of elastic fibers, including Cutis Laxa and profibrotic diseases such as Myhre’s syndrome. His research has contributed to the molecular and clinical characterization of these diseases.

Together with his team, he works on very rare forms of Cutis Laxa and identified several new genes and entities within the Cutis Laxa spectrum.

« Elastic fibers play a crucial role in the elasticity and mechanical properties of tissues such as the skin, lungs and blood vessels. We studied cutis laxa, a group of conditions characterized by loose and excessive skin folds, and Myhre’s syndrome, in which tissues harden or heal, to understand the structure and function of elastic fibers. This knowledge offers the possibility of finding treatments for age-related disorders. » (Pr Bert Callewaert ©Fondation AstraZeneca)

The AstraZeneca Award recognizes the innovative nature of his work and his contribution to the advancement of science.

🏆

Thesis on cases of Cutis Laxa

/in , , /by

Dr Thatjana Gardeitchik was a successful candidate with her thesis defence on 9th September 2024.

The title is: « Curious cases of Cutis Laxa , Insights into the diagnostics and patho-mechanisms of metabolic cutis laxa syndromes”.

You can find it online, in English only

(https://www.globalacademicpress.com/ebooks/thatjana_gardeitchik/)

Dermatology Days of Paris

/in , , , /by

03rd-06th December 2024

Dermatology Days of Paris (JDP)

Thanks to our stand during the JDP, I have had the great joy, more than 30 years later, to see again Dr Karim CHERTI.

At that time, he was a junior doctor in the genodermatosis unit at Hôpital Saint Louis in Paris. He was a member of the team who diagnosed my daughter, Cécile, and wrote his thesis on her case.

It was a very moving moment for both of us.